2016 American Transplant Congress
The Prevailing Preference for Left Nephrectomy in Living Donor Transplantation Does Not Adversely Affect Long Term Donor Outcome.
Background: There is a world-wide prevailing clinical bias for removing the left kidney for living donor renal transplant. Both the retrieval and implantation of the…2016 American Transplant Congress
Live Kidney Donors Have Significant Out-of-Pocket Costs Associated with Donation.
Johns Hopkins School of Medicine, Baltimore.
While financial barriers to transplantation have been recognized, limited data exists on the total non-reimbursed expense associated with live donation. Furthermore, donor costs have not…2016 American Transplant Congress
Age-Based High GFR Associates with Clinical Risk Among Potential Living Donors, but Only with Increased Nephron Number Among Approved Donors.
1Mayo Clinic, Arizona; 2Mayo Clinic, Rochester; 3Cleveland Clinic, OH.
Background:Association of high GFR with clinical and kidney structural characteristics among living donors has not been studied.Methods: Study cohort:potential kidney donors evaluated at Mayo Clinic…2016 American Transplant Congress
Donor-Candidate Mismatch in Age, Sex, HLA, and Body Size Inform a Calculator for Kidney Graft Survival.
1Univ of Michigan, Ann Arbor; 2Arbor Research, Ann Arbor, MI; 3Univ of Toledo, Toledo, OH.
Using Scientific Registry of Transplant Recipients data, we analyzed 232,705 kidney transplant recipients that received a transplant from 1998-2012. Graft failure rates were estimated using…2016 American Transplant Congress
Should Renin Angiotensin Blockade Be the Mainstay of Hypertension Treatment in Kidney Donors?
Introduction: The prevalence of hypertension (HTN) in kidney donors is comparable to what is seen in the general population. How HTN in donors is treated…2016 American Transplant Congress
5-Year Follow-Up After Live Donor Nephrectomy – A Prospective Cohort Study.
BackgroundRecently some studies have reported less favorable results after live kidney donation. We investigated therefore which donors will possibly be at risk for chronic kidney…2016 American Transplant Congress
Donor HLA Specific IgM Antibody Measured on Day 14 Post-Transplantation Predicts Poor Graft Survival in HLA-Incompatible Renal Transplantation.
Introduction: Role of IgG antibodies against donor human leucocyte antigens (HLA) is established in renal transplant monitoring. Role of IgM donor HLA specific antibodies (DSA)…2016 American Transplant Congress
Outcomes of Donor Nephrectomy in the Elderly.
PURPOSE: The critical organ shortage has increased demand for marginal donor kidneys. Although previously a contraindication to live kidney donation, advanced age donors (>60 y.o.)…2016 American Transplant Congress
Comparison of Renal Outcomes Between ABO-Incompatible and Kidney Paired Donation Transplantation In Living Donors.
Kidney Transplant Unit, UCSF, San Francisco, CA.
Introduction: ABO incompatible transplantation (ABOi Tx) broadens the donor pool and decreases wait times for patients who don't have a blood type compatible living kidney…2016 American Transplant Congress
Clinical Outcome of Elderly Living Kidney Donors: A Single-Center Study in Japan.
Urology, Tokyo Women's Medical University, Tokyo, Japan.
Background: Previous studies and current guidelines have suggested that elderly persons can be living kidney donors; however, reports on elderly donors >70 years old are…
American Transplant Congress abstracts